A thriving healthcare industry, backed by an expanding geriatric population has fueled the growth of the global heparin market. Heparin is an anticoagulant or blood thinner, which prevents the formation of blood clots. The market research report provides a clear understanding of the heparin industry by determining and analyzing its various types, applications, end-users, and regional markets. The market size, share, growth rate, and trends are some of the important data that the report focuses on.
The scope and dynamics of the market during the forecast period of 2012 to 2018 are discussed at length and the key driving forces and challenges are highlighted. In addition, the high revenue generating, prospective and emerging segments are also mentioned in the research report.
The report also describes the current competitive scenario, listing leading vendors, their profiles, product portfolios, individual industry share and strengths and weaknesses, and the threats faced by them.
Overview of the global heparin market
On the basis of type, the market for heparin can be segmented into heparin and low molecular weight heparin. Low molecular weight heparin can be further segmented into tinzaparin, enoxaparin, and dalteparin. Each of the low molecular weight heparins are used for anticoagulation in conditions such as hemodialysis, deep vein thrombosis (DVT), renal impairment, pulmonary embolism, venous thromboembolism (VTE), and angina blood vessel complications. On the basis of end-users, the market can be divided into hospitals, laboratories, medical practitioner offices, and emergency care centers.
The global heparin market has seen a surge in R&D activities, expanding the reach of heparins. Drug manufacturers have been taking initiatives to explore new applications for heparins, which has been a prominent factor driving the market. There has also been a rise in healthcare expenditure in emerging economies such as China, who has also stepped up efforts and investments in medical research. Moreover, exporting standards for heparin have been lifted and a positive economic growth has been witnessed in Asian countries, making it the fastest growing regional markets during the forecast period.
Geographically, North America dominated the global heparin market in 2011 in terms of overall industry share, while dalteparin accounted for the major share among other low molecular weight heparins.
Companies mentioned in the research report
The vendors operating in the global heparin market include Leo Pharma Inc., Pfizer Inc., Sanofi S.A., GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd., Shanghai No. 1 Biochemical Pharmaceutical Co. Ltd., Bristol-Myers Squibb Co., Celgene Corp., Baxter Healthcare Corp., Wanbang Biochemical Pharmaceutical Co. Ltd., and Mitsubishi Tanabe Pharma Corp.
Major geographies analyzed under this research report are:
- North America
- Rest of the World
This report gives you access to decisive data such as:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Key highlights of this report
- Overview of key market forces propelling and restraining market growth
- Up-to-date analyses of market trends and technological improvements in the micro servers industry
- Pin-point analyses of market competition dynamics to offer you a competitive edge
- An analysis of strategies of major competitors
- An array of graphics and SWOT analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Offers a clear understanding of the competitive landscape and key product segments
Table of Contents
TABLE OF CONTENT
1.1. Report Description
1.2. Research Methodology
1.3. Market Segmentation
1.4. List of Acronyms
2. Executive Summary
3. Global Heparin Market Overview
3.1. Market Trends and Future Outlook, 2010 - 2018
3.2. Growth Drivers
3.2.1. Impact Analysis of the Growth Drivers
3.3. Growth Restraints
3.3.1. Impact Analysis of the Growth Restraints
3.4. Growth Opportunities
3.4.1. Impact Analysis of the Growth Opportunities
3.5. Porter’s Five Forces Analysis for the Heparin Market
3.6. Pipeline and New Product Analysis
4. Global Heparin Market, by Types, Market Size and Forecast, 2010 – 2018 (USD Million)
4.1. Heparin Market
4.2. Low Molecular Weight Heparin Market
5. Global Heparin Market, by Application Areas, Market Size and Forecast, 2010 – 2018 (USD Million)
5.1.1. Deep Vein Thrombosis (DVT)
5.1.2. Pulmonary Embolism
5.1.4. Renal Impairment
5.1.5. Venous Thromboembolism (VTE)
5.2.1. Deep Vein Thrombosis (DVT)
5.2.2. Pulmonary Embolism
5.2.4. Renal Impairment
5.2.5. Angina Blood Vessel Complications
5.3.1. Deep Vein Thrombosis (DVT)
5.3.2. Pulmonary Embolism
5.3.4. Renal Impairment
6. Global Heparin Market, by End-Users, Market Size and Forecast, 2010 – 2018 (USD Million)
6.3. Emergency Care Centers
6.4. Medical Practitioner Offices
7. Global Heparin Market, by Geography, Market Size and Forecast, 2010 – 2018 (USD Million)
7.2. North American Heparin Market
7.3. European Heparin Market
7.4. Asia Pacific Heparin Market
7.5. Rest of the World
8. Competitive Landscape
8.1. Market share by Key Players, 2011
8.2. Competitive strategy by Key Players
9.1. Market Strategy for Success
9.2. Barriers to be Considered
10. Company Profiles
10.1. Bristol-Myers Squibb Co.
10.2. Leo Pharma Inc.
10.3. Celgene Corp.
10.4. Baxter Healthcare Corp.
10.5. Pfizer Inc.
10.6. Mitsubishi Tanabe Pharma Corp.
10.7. Sanofi S.A.
10.8. GlaxoSmithKline PLC